Výsledky vyhledávání - "Michela Forti"

Akademický článek

Molecular characterization of a complex small supernumerary marker chromosome derived from chromosome 18p: an addition to the literature

Autor: Eleonora Marchina, Michela Forti, Mariella Tonelli, Stefania Maccarini, Francesca Malvestiti, Chiara Piantoni, Elena Filippini, Elisa Fazzi, Giuseppe Borsani

Publikováno v: Molecular Cytogenetics, Vol 14, Iss 1, Pp 1-8 (2021)

Abstract Background Small supernumerary marker chromosomes (sSMC) are a heterogeneous group of structurally abnormal chromosomes, with an incidence of 0,044% in newborns that increases up to almost 7 times in developmentally retarded patients. sSMC f

Externí odkaz: https://doaj.org/article/60680abd01ed4a68bb010ea73d146dc3

Zobrazit plný text záznamu

Plný text ve formátu HTML

Molecular characterization of a complex small supernumerary marker chromosome derived from chromosome 18p: an addition to the literature

Autor: Chiara Piantoni, Stefania Maccarini, Francesca Malvestiti, Elena Filippini, Eleonora Marchina, Elisa Fazzi, Giuseppe Borsani, Michela Forti, Mariella Tonelli

Publikováno v: Molecular Cytogenetics, Vol 14, Iss 1, Pp 1-8 (2021)
Molecular Cytogenetics

Background Small supernumerary marker chromosomes (sSMC) are a heterogeneous group of structurally abnormal chromosomes, with an incidence of 0,044% in newborns that increases up to almost 7 times in developmentally retarded patients. sSMC from all 2

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1998e2d23ff8c1e49000b9d2868751e
https://doaj.org/article/60680abd01ed4a68bb010ea73d146dc3

Zobrazit plný text záznamu

Plný text ve formátu HTML

Neoadjuvant Treatment Approach: The Rosetta Stone for Breast Cancer?

Autor: Laura Zanotti, Alfredo Berruti, Michela Forti, Maria Rosa Cappelletti, Vito Amoroso, Manuela Milani, Sandra Sigala, Mario Martinotti, Edda Simoncini, Daniele Generali, Francesca Bedussi, Mara Ardine, Alberto Bottini, Carla Strina

Publikováno v: Journal of the National Cancer Institute. Monographs. 2015(51)

Breast cancer represents a heterogeneous group of diseases with varied biological features, behavior, and response to therapy; thus, management of breast cancer relies on the availability of robust predictive and prognostic factors to support therapy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bccd3d031c0376256537b09b7b12036a
https://pubmed.ncbi.nlm.nih.gov/26063883

Zobrazit plný text záznamu

Effect of primary letrozole treatment on tumor expression of mTOR and HIF-1α and relation to clinical response

Autor: Giulia Brugnoli, Mara Ardine, Laura Zanotti, Maria Rosa Cappelletti, Maria Elena Vailati, Daniele Generali, Ramona Bertoni, Sergio Aguggini, Adrian L Harris, G Allevi, Giuseppina Ferrero, Alfredo Berruti, Alberto Bottini, Carla Strina, Francesca Bedussi, Manuela Milani, Michela Forti, Stephen B. Fox

INTRODUCTION: Recently the combination of the mammalian target of rapamycin (mTOR) inhibitor everolimus and the aromatase inhibitor exemestane has been shown to double the progression-free survival rate in advanced breast cancer. However, the effect

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62a98c535b03c23c891737deeb457fc9
http://hdl.handle.net/11368/2903815